UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003487 |
|---|---|
| Receipt number | R000004220 |
| Scientific Title | Phase II study of cisplatin plus S-1 with bevacizumab as first-line therapy for stage III/IV nonsquamous non-small-cell lung cancer |
| Date of disclosure of the study information | 2010/04/16 |
| Last modified on | 2012/04/04 13:35:03 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/04/14 00:31:46 | ||
| 2 | Update | 2012/04/04 13:33:55 | Organization Organization Institute Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 |
|
| 3 | Update | 2012/04/04 13:35:03 | Recruitment status |
